Marquet, Pierre http://orcid.org/0000-0001-7698-0760
Destère, Alexandre
Monchaud, Caroline
Rérolle, Jean-Philippe
Buchler, Matthias
Mazouz, Hakim
Etienne, Isabelle
Thierry, Antoine
Picard, Nicolas
Woillard, Jean-Baptiste
Debord, Jean
Funding for this research was provided by:
Sandoz France
CHU de Limoges
Article History
Accepted: 30 October 2020
First Online: 24 November 2020
Declarations
:
: This study was funded by Sandoz France and Limoges University Hospital.
: Pierre Marquet received consulting fees and travel grants from Sandoz, Chiesi, Pfizer, and BMS and research grants from Sandoz and Chiesi. Caroline Monchaud received an honorarium from Chiesi to participate in a board of experts. Matthias Buchler received a travel grant to attend an international congress from Sandoz. Jean-Baptiste Woillard received speaker fees from Chiesi and Gilead and travel grants to attend symposia or congresses from Chiesi and Gilead, VIIV, Astellas and Abbvie. Alexandre Destere, Jean-Philippe Rérolle, Hakim Mazouz, Isabelle Etienne, Antoine Thierry, Nicolas Picard and Jean Debord have no conflicts of interest that are directly relevant to the content of this article.
: This study was approved by the National Research Ethics Committee CPP16-058 on 8 December, 2016 and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Informed consent was obtained from all participants included in the study.
: Not applicable.
: Raw data are available on request from the authors.
: Not applicable.
: PM designed and was the principal investigator of the study, participated in result analysis and interpretation, and is the main author of the manuscript. AD participated in data analysis and participated in manuscript writing. CM participated in the study design, supervised the clinical research team, data collection and cleaning, and participated in manuscript writing. J-PR enrolled patients in the study and critically reviewed the manuscript. MB enrolled patients in the study and critically reviewed the manuscript. HM enrolled patients in the study and critically reviewed the manuscript. IE enrolled patients in the study and critically reviewed the manuscript. AT enrolled patients in the study and critically reviewed the manuscript. NP supervised pharmacogenetic testing and critically reviewed the manuscript. J-BW participated in the pharmacokinetic modelling and manuscript writing. JD performed most of the pharmacokinetic modelling and Bayesian estimation and participated in manuscript writing.